These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17443225)

  • 1. Development of adult T-cell leukemia in donor-derived human T-cell leukemia virus type I-infected T cells after allogeneic bone marrow transplantation.
    Tamaki H; Taniguchi Y; Kikuchi A; Yamagami T; Soma T; Matsuoka M
    Leukemia; 2007 Jul; 21(7):1594-6. PubMed ID: 17443225
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-derived T-cell leukemia after bone marrow transplantation.
    Tamaki H; Matsuoka M
    N Engl J Med; 2006 Apr; 354(16):1758-9. PubMed ID: 16625020
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
    Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More on donor-derived T-cell leukemia after bone marrow transplantation.
    Focosi D; Petrini M
    N Engl J Med; 2006 Jul; 355(2):212-3; author reply 213. PubMed ID: 16837689
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistent infection with human T lymphotropic virus type 1 after allogeneic bone marrow transplantation from a seronegative donor.
    Kanda Y; Taketazu F; Chiba S; Yazaki Y; Hirai H
    Bone Marrow Transplant; 1999 Aug; 24(3):349. PubMed ID: 10455380
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia.
    Ogata M; Ogata Y; Imamura T; Ohtsuka E; Kikuchi H; Utsunomiya A; Yashiki S; Sonoda S; Nasu M
    Bone Marrow Transplant; 2002 Nov; 30(10):699-701. PubMed ID: 12420209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult T-cell leukemia successfully treated with allogeneic bone marrow transplantation.
    Tajima K; Amakawa R; Uehira K; Matsumoto N; Shimizu T; Miyazaki Y; Fujimoto M; Kishimoto Y; Fukuhara S
    Int J Hematol; 2000 Apr; 71(3):290-3. PubMed ID: 10846838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation.
    Kawano N; Shimoda K; Ishikawa F; Taketomi A; Yoshizumi T; Shimoda S; Yoshida S; Uozumi K; Suzuki S; Maehara Y; Harada M
    Transplantation; 2006 Sep; 82(6):840-3. PubMed ID: 17006333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation.
    Au WY; Lam CC; Lie AK; Pang A; Kwong YL
    Am J Clin Pathol; 2003 Oct; 120(4):626-30. PubMed ID: 14560574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
    Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-lymphocyte purification of donor bone marrow in allogeneic bone marrow transplantation for leukemia: a step ahead or a breakthrough?].
    von dem Borne AE
    Ned Tijdschr Geneeskd; 1986 May; 130(19):852-4. PubMed ID: 3520347
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders.
    Chang H; Kamel-Reid S; Hussain N; Lipton J; Messner HA
    Am J Clin Pathol; 2005 Feb; 123(2):196-9. PubMed ID: 15842042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence and longevity of peripherally expanded donor-derived TCRalphabeta+ mature T lymphocyte clones after allogeneic bone marrow transplantation for adult myeloid leukemias.
    Saitoh H; Hirokawa M; Fujishima N; Ichikawa Y; Kawabata Y; Miura I; Miura AB; Matsutani T; Suzuki R; Sawada K
    Leukemia; 2003 Aug; 17(8):1626-35. PubMed ID: 12886252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Donor leukocyte transfusion in a patient with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation: analysis of natural killer cell activity and T-cell receptor repertoire in bone marrow T cells that exhibited graft-versus-leukemia activity].
    Suehiro Y; Muta K; Umemura T; Motomura S; Nishimura J; Nawata H; Kimura N
    Rinsho Ketsueki; 1999 Jan; 40(1):40-5. PubMed ID: 10067095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
    Papadopoulos EB; Ladanyi M; Emanuel D; Mackinnon S; Boulad F; Carabasi MH; Castro-Malaspina H; Childs BH; Gillio AP; Small TN
    N Engl J Med; 1994 Apr; 330(17):1185-91. PubMed ID: 8093146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.